https://de.marketscreener.com/kurs/aktie/SANTHERA-PHARMACEUTICALS--195471/news/SANTHERA-PHARMACEU-Laufende-Studien-verunmoglichen-CHMP-Prufung-unter-Richtlinie-fur-kleine-Pat-545470/?utm_source=telegram&utm_medium=social&utm_campaign=share